Luna Innovations Incorporated (LUNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional […]

ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DMC Global Inc. (BOOM) and Encourages Investors to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. ("DMC Global" or "the Company") (NASDAQ:BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nextracker Inc. (NXT) and Encourages Shareholders to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional information

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Cummins Inc. (CMI) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cummins Inc. ("Cummins" or "the Company") (NYSE:CMI). Investors who purchased Cummins securities prior to April 30, 2019, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Methode Electronics, Inc. (MEI) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. ("Methode Electronics" or "the Company") (NYSE:MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero"or "the Company") (NASDAQ:AKRO). Investors who purchased Akero securities prior to September 13, 2022, and continue to hold to the present, are encouraged to obtain additional

Integral Ad Science Holding Corp. (IAS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS). Investors who purchased IAS securities prior to March 2, 2023, and continue to hold to the present, are encouraged to

Scroll to Top